Susquehanna International Group, LLP Neogenomics Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $611,040 - $808,488	45,600 Added 10.63%	474,400 $7 Million
Q2 2024 Aug 15, 2024	SELL	$13.01 - $15.77 $2.06 Million - $2.5 Million	-158,500 Reduced 26.99%	428,800 $5.95 Million
Q1 2024 May 07, 2024	BUY	$14.06 - $16.79 $897,028 - $1.07 Million	63,800 Added 12.19%	587,300 $9.23 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $4.56 Million - $8.1 Million	390,800 Added 294.5%	523,500 $8.47 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $3,645 - $5,355	-300 Reduced 0.23%	132,700 $1.63 Million
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $661,290 - $930,026	-46,900 Reduced 26.07%	133,000 $2.14 Million
Q1 2023 May 16, 2023	BUY	$9.09 - $19.45 $415,413 - $888,865	45,700 Added 34.05%	179,900 $3.13 Million
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $303,795 - $568,497	-47,100 Reduced 25.98%	134,200 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $231,084 - $379,554	29,400 Added 19.35%	181,300 $1.56 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $874,734 - $1.73 Million	123,900 Added 442.5%	151,900 $1.24 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $19,440 - $56,448	-1,600 Reduced 5.41%	28,000 $340,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $2.15 Million - $3.42 Million	-70,600 Reduced 70.46%	29,600 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $674,892 - $850,824	16,200 Added 19.29%	100,200 $4.83 Million
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $351,552 - $496,224	-9,600 Reduced 10.26%	84,000 $3.79 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $1.6 Million - $2.31 Million	38,500 Added 69.87%	93,600 $4.51 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $339,152 - $530,818	9,400 Added 20.57%	55,100 $2.97 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $1.26 Million - $1.53 Million	-37,900 Reduced 45.33%	45,700 $1.69 Million
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $1.06 Million - $1.36 Million	-43,900 Reduced 34.43%	83,600 $2.59 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $1.62 Million - $2.73 Million	79,000 Added 162.89%	127,500 $3.52 Million
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $1.72 Million - $2.12 Million	-87,800 Reduced 64.42%	48,500 $1.06 Million
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $906,858 - $1.53 Million	74,700 Added 121.27%	136,300 $2.79 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $319,216 - $525,400	28,400 Added 85.54%	61,600 $777,000
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $97,500 - $119,964	7,800 Added 30.71%	33,200 $510,000
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $31,812 - $38,544	-4,400 Reduced 14.77%	25,400 $207,000
Q4 2017 Feb 14, 2018	SELL	$8.02 - $11.18 $236,590 - $329,810	-29,500 Reduced 49.75%	29,800 $264,000
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $540,223 - $667,718	59,300	59,300 $660,000

Others Institutions Holding NEO

# of Institutions

292

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$366 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$261 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$128 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$123 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$122 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.34B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account